A carregar...
A Sum Score to Define Therapy-Refractory Myasthenia Gravis: A German Consensus
BACKGROUND AND PURPOSE: In 2017, eculizumab has been approved for treatment-refractory generalised myasthenia gravis (TRgMG). The German Myasthenia Foundation has published a consensus statement on the use of eculizumab, with a recent update. However, a treatment-refractory state is still ill-define...
Na minha lista:
| Publicado no: | J Cent Nerv Syst Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7863150/ https://ncbi.nlm.nih.gov/pubmed/33597816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179573521989151 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|